ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

January 14, 1994

Carmona’s Term as Surgeon General Expires.

August 4, 2006

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

DCCP To Have Board Of Scientific Counselors

September 1, 1978

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011